Schering’s Lotrimin Ultra Only Rx-To-OTC Switch Of 2001
This article was originally published in The Tan Sheet
Executive Summary
Schering-Plough's Lotrimin Ultra topical antifungal was the first Rx-to-OTC switch drug approved by FDA in 25 months and the only switch in 2001
You may also be interested in...
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7
Novartis Consumer Health Reshuffled, Functional Foods On Sales Block
Novartis is reorganizing its consumer health division by grouping together three businesses - OTC drugs, infant and baby and medical nutrition - and operating animal health and Ciba Vision as separate units, the firm stated during a year-end analysts call Feb. 7